Regarding takeover,
Since you mentioned about Celegne, do you know, if they have sold their stake in Mesoblast? I went through their annual reports for FY 2015, 2016, 2017 & 2018. Nothing mentioned about Mesoblast. However, they got approximately 81 million dollars worth of marketable securities in their balance sheet. It's a fair value and what i observed was, value of their initial equity investments has decreased. Now question is, which companies equity does this marketable securities comprise? I couldn't locate any disclosure on this. Therefore, i couldn't conclude whether or not their MS consist MSB equity .
Mesoblast - takeover target?, page-9
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.055(4.66%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $4.824M | 4.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25589 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |